<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34997549</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1559-0283</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>80</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Cell biochemistry and biophysics</Title>
          <ISOAbbreviation>Cell Biochem Biophys</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Galanin enhanced insulin-mediated intracellular signaling by regulating the stability of membrane-localized insulin/IR.</ArticleTitle>
        <Pagination>
          <StartPage>321</StartPage>
          <EndPage>330</EndPage>
          <MedlinePgn>321-330</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12013-021-01049-x</ELocationID>
        <Abstract>
          <AbstractText>Previous studies have shown that insulin has the important regulatory effect on the intestinal tract. However, until now, the biological properties of insulin on intestinal cell has not been revealed. Therefore, in the current research, we first studied the cell characteristics and signaling profiles of insulin in the intestinal cell model, and found that insulin can be internalized into the cytoplasm in a time-dependent manner. After internalization, insulin transported into different type of endosomes. More importantly, we explored the effect of galanin on insulin-mediated signaling pathways (galanin is a polypeptide composed of 29 amino acid residues, galanin is widely distributed in the central and peripheral nervous system and has a variety of biological activities), and found that galanin can increase insulin sensitivity by regulating insulin receptor (IR)-mediated signal transduction pathways. We further study the potential molecular mechanism by which galanin enhances insulin sensitivity, and found that galanin could increase the time of insulin acting on the cell membrane. Further experiments showed that galanin could stabilize the membrane-localized insulin/IR, which may be an important new potential mechanism by which galanin improves the biological activity of insulin. This study laid the foundation for exploring the relationship between galanin and insulin sensitivity.</AbstractText>
          <CopyrightInformation>© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>GuangZhi</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0001-7450-7590</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medicine, Jiangsu College of Nursing, HuaiAn, 223005, Jiangsu Province, China. guangzhili@jscn.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qin</LastName>
            <ForeName>Yongting</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0002-9662-9799</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medicine, Jiangsu College of Nursing, HuaiAn, 223005, Jiangsu Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Shizhen</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-7062-9021</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medicine, Jiangsu College of Nursing, HuaiAn, 223005, Jiangsu Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ni</LastName>
            <ForeName>Jie</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-5602-7400</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Basic Medicine, Jiangsu College of Nursing, HuaiAn, 223005, Jiangsu Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Dongmei</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0001-8989-0086</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Pharmacy and Traditional Chinese Medicine, Jiangsu College of Nursing, HuaiAn, 223005, Jiangsu Province, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>08</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cell Biochem Biophys</MedlineTA>
        <NlmUniqueID>9701934</NlmUniqueID>
        <ISSNLinking>1085-9195</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>88813-36-9</RegistryNumber>
          <NameOfSubstance UI="D019004">Galanin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.10.1</RegistryNumber>
          <NameOfSubstance UI="D011972">Receptor, Insulin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D019004" MajorTopicYN="Y">Galanin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007333" MajorTopicYN="Y">Insulin Resistance</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011972" MajorTopicYN="N">Receptor, Insulin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Galanin</Keyword>
        <Keyword MajorTopicYN="N">Insulin is a proinsulin</Keyword>
        <Keyword MajorTopicYN="N">Intestinal tract</Keyword>
        <Keyword MajorTopicYN="N">Signaling pathway</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>13</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34997549</ArticleId>
        <ArticleId IdType="doi">10.1007/s12013-021-01049-x</ArticleId>
        <ArticleId IdType="pii">10.1007/s12013-021-01049-x</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Stenvers, D. J., Scheer, F. A., Schrauwen, P., la Fleur, S. E., &amp; Klabee, A. (2019). Circadian clocks and insulin resistance. Nature Reviews Endocrinology, 15, 75–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41574-018-0122-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ziegler, T. R., Almahfouz, A., Pedrini, M. T., &amp; Smith, R. J. (1995). A comparison of rat small intestinal insulin and igf-i receptors during fasting and refeeding. Endocrinology, 136, 5148–5154.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/endo.136.11.7588253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Czech, M. P. (2020). Mechanisms of insulin resistance related to white, beige, and brown adipocytes. Molecular Metabolism, 34, 27–42.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molmet.2019.12.014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazarati, A. M. (2004). Galanin and galanin receptors in epilepsy. Neuropeptides, 38, 331–343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.npep.2004.07.006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mitsukawa, K., Lu, X., &amp; Bartfai, T. (2008). Galanin, galanin receptors and drug targets. Experientia Supplementum, 102, 7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-3-0346-0228-0_2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He, B., Shi, M., Zhang, L., Li, G., Zhang, L., Shao, H., &amp; Sui, Y. (2011). Beneficial effect of galanin on insulin sensitivity in muscle of type 2 diabetic rats. Physiology &amp; Behavior, 103, 284–289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.physbeh.2011.02.023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang, G., Wang, Y., Park, S., Bajpayee, N. S., Vi, D., Nagaoka, Y., &amp; Jiang, M. (2012). Go2 G protein mediates galanin inhibitory effects on insulin release from pancreatic β cells. Proceedings of the National Academy of Sciences USA, 109, 2636–2641.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1200100109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kootte, R. S., Levin, E., Salojärvi, J., Smits, L. P., Hartstra, A. V., Udayappan, S. D., &amp; Nieuwdorp, M. (2017). Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metabolism, 26, 611–619.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2017.09.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim, K. S., Kwag, D., Hwang, H., Lee, S. &amp; Bae, E. S. (2018). Immense insulin intestinal uptake and lymphatic transportusing bile acid conjugated partially uncapped liposome. Molecular Pharmaceutics, 15, 4756–4763.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.molpharmaceut.8b00708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Argilés, M., Zegrí, A., Arbós, J., García, C., &amp; López-Soriano, F. J. (1992). The role of insulin in the intestinal absorption of glucose in the rat. International Journal of Biochemistry, 24(4), 631–636.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0020-711X(92)90339-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sukhotnik, I., Shehadeh, N., Shamir, R., Bejar, J., Bernshteyn, A., &amp; Mogilner, J. G. (2005). Oral insulin enhances intestinal regrowth following massive small bowel resection in rat. Digestive Diseases &amp; Sciences, 50(12), 2379–2385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10620-005-3067-x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vigneri, R., Goldfine, I. D., &amp; Frittitta, L. J. J. O. E. I. (2016). Insulin, insulin receptors, and cancer. Journal of Endocrinological Investigation, 39, 1365–1376.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s40618-016-0508-7</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hajduch, E., Alessi, D. R., Hemmings, B. A., &amp; Hundal, H. S. (1998). Constitutive activation of protein kinase Balpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivatio n of glycogen synthase kinase 3 in L6 muscle cells. Diabetes, 47, 1006–1013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.47.7.1006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwanaga, K., Ono, S., Narioka, K., Morimoto, K., Kakemi, M., Yamashita, S., &amp; Oku, N. (1997). Oral delivery of insulin by using surface coating liposomes: improvement of stability of insulin in GI tract. International Journal of Pharmaceutics, 157, 73–80.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0378-5173(97)00237-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vrontakis, M. E. (2002). Galanin: a biologically active peptide. Current Drug Targets-CNS &amp; Neurological Disorders, 1, 531–541.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1568007023338914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kyrkouli, S. E., Stanley, B. G., Seirafi, R. &amp; Leibowitz, D. (1990). Stimulation of feeding by galanin: anatomical localization and behavioral specificity of this peptide’s effects in the brain. Peptides, 11, 995–1001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0196-9781(90)90023-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jochen, A. L., Hays, J., &amp; Mick, G. (1995). Inhibitory effects of cerulenin on protein palmitoylation and insulin internalization in rat adipocytes. Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism, 1259, 65–72.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0005-2760(95)00147-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Benzi, L., Cecchetti, P., Ciccarone, A., Novelli, S., Paoli, A., Bertacca, A., Maffei, M., Maggi, D., Andraghetti, G., Del Prato, S. &amp; Cordera, R. (2003). The extracellular portion of the insulin receptor beta-subunit regulates the cellular trafficking of the insulin-insulin receptor complex. Studies on Chinese hamster ovary cells carrying the cys 860−−&gt;ser insulin receptor mutation. European Journal of Endocrinology, 148(3), 365–71.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/eje.0.1480365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang, Y., Sheng, S., Fang, P., Ma, Y., Li, J., Shi, Q., &amp; Shi, M. (2012). Exercise-induced galanin release facilitated GLUT4 translocation in adipocytes of type 2 diabetic rats. Pharmacology Biochemistry and Behavior, 100, 554–559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pbb.2011.10.026</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
